CHE shareholder files Form 144 to sell common stock

Rhea-AI Filing Summary

CHE has a Form 144 notice indicating a planned sale of 2,000 common shares. The shares are to be sold through Raymond James & Associates on or about 11/24/2025 on the NYSE, with an aggregate market value of $876,000. Shares outstanding were 14,110,000; this is a baseline figure, not the amount being sold.

The seller acquired the shares through stock awards from the issuer in 2016. The filing also lists prior sales over the past three months by Kevin J McNamara, including 1,000 common shares for gross proceeds of $460,647 and 2,000 common shares for $922,794, both on 09/26/2025. The signer represents they are not aware of undisclosed material adverse information about the issuer.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	2000	876000.00	14110000	11/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2016	Stock Award	Issuer			1274	08/01/2016	Stock Award
Common	05/26/2016	Stock Award	Issuer			628	05/26/2016	Stock Award
Common	06/06/2016	Stock Award	Issuer			98	06/06/2016	Stock Award

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin J McNamara 2349 Grandin Road Ste 2600 Cincinnati OH 45208	Common	09/26/2025	1000	460647.00
Kevin J McNamara 2349 Grandin Road Ste 2600 Cincinnati OH 45208	Common	09/26/2025	2000	922794.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CHE Form 144 filing disclose?

The Form 144 for CHE discloses a planned sale of 2,000 shares of the issuer's common stock, to be executed through Raymond James & Associates on or about 11/24/2025 on the NYSE, with an aggregate market value of $876,000.

How many CHE shares are planned to be sold under this Form 144?

The notice covers 2,000 common shares of CHE, with an indicated aggregate market value of $876,000 at the time of the filing.

How many CHE shares were outstanding in this Form 144 excerpt?

The Form 144 excerpt reports that the number of CHE common shares outstanding was 14,110,000, providing context for the planned sale amount.

Who is the selling security holder in the CHE Form 144 and how were the shares acquired?

The selling holder identified is Kevin J McNamara. The shares to be sold were acquired through stock awards from the issuer in 2016, with multiple award dates listed.

What prior CHE share sales are disclosed for the last 3 months?

The filing lists prior sales during the past three months by Kevin J McNamara: 1,000 common shares sold on 09/26/2025 for gross proceeds of $460,647 and 2,000 common shares sold the same day for $922,794.

What representation does the seller make in the CHE Form 144?

By signing the notice, the seller represents that they do not know of any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, and this representation also applies as of any stated Rule 10b5-1 plan adoption date.